Admission to Trading

Summary by AI BETAClose X

GSK plc has announced the admission of 96,525 ordinary shares of 31¼ pence each to trading on the London Stock Exchange's Main Market. These shares, admitted under existing block listing arrangements for the GlaxoSmithKline plc Share Save Plans 2012 and 2022, are fully fungible with the company's existing ordinary shares. Following this admission, the total number of ordinary shares admitted to trading stands at 4,316,176,278. This notification covers the period from 23 January 2026 to 20 March 2026.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings